0001179110-14-004581.txt : 20140305
0001179110-14-004581.hdr.sgml : 20140305
20140305190553
ACCESSION NUMBER: 0001179110-14-004581
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140303
FILED AS OF DATE: 20140305
DATE AS OF CHANGE: 20140305
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: THERAVANCE INC
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6508086000
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: S. SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shafer Bradford J
CENTRAL INDEX KEY: 0001302448
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 14670952
MAIL ADDRESS:
STREET 1: 901 GATEWAY BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
edgar.xml
FORM 4 -
X0306
4
2014-03-03
0
0001080014
THERAVANCE INC
THRX
0001302448
Shafer Bradford J
THERAVANCE, INC.
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Sr VP, Gen. Counsel, Secretary
Common Stock
2014-03-03
4
M
0
30967
9.6875
A
326731
D
Common Stock
2014-03-03
4
M
0
65806
9.6875
A
392537
D
Common Stock
2014-03-03
4
S
0
64006
36.72
D
328531
D
Common Stock
2014-03-03
4
S
0
1800
37.23
D
326731
D
Common Stock
2750
I
by child's trust
Common Stock
2750
I
by child's trust
Common Stock
2750
I
by child's trust
Stock Option (Right to Buy)
9.6875
2014-03-03
4
M
0
30967
0
D
2014-03-28
Common Stock
30967
0
D
Stock Option (Right to Buy)
9.6875
2014-03-03
4
M
0
65806
0
D
2014-03-28
Common Stock
65806
0
D
DISPOSITIONS MADE PURSUANT TO A PLAN INTENDED TO COMPLY WITH RULE 10b5-1(c).
This transaction was executed in multiple trades at prices from $36.19 to $37.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices from $37.19 to $37.24. The price reported above reflects the weighted average sale price.
Shares held in trust for the benefit of a child of the reporting person. Reporting person is a trustee of the trust. Reporting person disclaims beneficial ownership of these shares.
Exercisable immediately.
Bradford J. Shafer
2014-03-05